Founder & CEO
Andreu Soldevila Fàbrega undertook his academic training at UAB and UPC, where hecompleted a BA in Biological Sciences, BA in Biotechnology, MA in Genetics and Microbiology, MA in Environmental Sciences and a PhD in Biology. His interests have always been related to research and development in the biologics field and its translation to innovation in the market in order to provide solutions for healthcare which are environmentally friendly. For the past 16 years Andreu has been building a career in Biotechnology, specifically in Microbiology, Industrial Biotechnology, Proteomics and Biotherapeutics including NBE’s and Biosimilars. Andreu worked in the discovery and development of biological products in IUCT, a SME placed in Barcelona, before moving to IPSEN Pharma, a Multinational company based in Paris, where he developed a proteomics platform for the characterization of biotherapeutics and for its multiplex absolute quantitation at picomolar level in biological fluids. This followed a high throughput approach which is useful for PK-PD studies, from lead screening to clinical studies. Andreu’s experience of heading the R&D department of 3PBiopharmaceuticals allowed him to further his knowledge in Biopharma field. He specialised in cell line development, process development and analytical development for biotherapeutics while also contributing to Scale up and Tech transfer. Andreu is currently heading a project called Leanbio, a company created in 2014 with expectation to become a reference in Biologics in southern Europe, providing solutions and products worldwide from 2015 onwards.
Genetics and Microbiology